| Detected | Trial | Change |
|---|---|---|
| 2026-07-29 | NCT05282901 Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal… |
Trial completed |
| 2026-07-29 | NCT05282901 Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal… |
date change Primary completion moved earlier: 2026-10-30 -> 2025-04-28 |
| 2026-07-29 | NCT05282901 Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal… |
date change Completion moved earlier: 2026-11-15 -> 2026-07-09 |
| 2026-07-24 | NCT07491380 Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6… |
Recruitment opened |
| 2026-07-24 | NCT07491380 Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6… |
date change Primary completion pushed: 2027-12-15 -> 2028-01-23 |
| 2026-07-24 | NCT07491380 Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6… |
date change Completion pushed: 2028-12-15 -> 2029-01-23 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05439005 | Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the… | Breast Cancer | Recruiting |
| NCT06195709 | ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic… | Breast Carcinoma | Recruiting |
| Phase 2/3 | |||
| NCT04681417 | Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management… | Retinoblastoma | Recruiting |
| Phase 2 | |||
| NCT05955170 | Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic… | HER2-positive Breast Cancer | Recruiting |
| NCT07193394 | Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer | Metastatic Breast Cancer ( HER2 Negative) | Recruiting |
| NCT06659705 | Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI) | Pancreatic Ductal Adenocarcinoma (PDAC) | Recruiting |
| NCT07111117 | Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in… | Neuroblastoma | Not Yet Recruiting |
| NCT02866136 | Conservative Treatments of Retinoblastoma | Retinoblastoma | Active, Not Recruiting |
| NCT02870907 | Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE… | Retinoblastoma | Active, Not Recruiting |
| NCT06175390 | Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer | Triple Negative Breast Cancer | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT04446962 | LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate… | Lymphoma, Large B-Cell, Diffuse | Active, Not Recruiting |
| Not specified | |||
| NCT05192980 | SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With… | Neuroblastoma | Recruiting |
| NCT04424719 | Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME) | Uveal Melanoma | Recruiting |
| NCT07158879 | Skin Reactions Related to Thoracic Implantable Chamber Dressings | Skin Diseases | Recruiting |
| NCT04790682 | LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small… | Metastatic Lung Cancer | Recruiting |
| NCT06349512 | 68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer… | Triple Negative Breast Cancer | Recruiting |
| NCT07357311 | Screening and Care for Fear of Cancer Recurrence in Patients With Cancer at Institut Curie | Lung Cancer | Recruiting |
| NCT06459791 | Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From… | Metastatic Breast Cancer | Recruiting |
| NCT03017573 | Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link… | Ovarian Cancer | Recruiting |
| NCT05781295 | Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in… | Children | Recruiting |
| NCT05088395 | Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4 | Cancer | Recruiting |
| NCT04731610 | Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy… | Thymoma Malignant Recurrent | Recruiting |
| NCT05475366 | Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using… | Carcinoma, Pancreatic Ductal | Recruiting |
| NCT05354765 | Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer… | Cancer | Recruiting |
| NCT07571564 | Adherence to Enteral Nutrition | Enteral Nutrition | Recruiting |